The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.
One cancer survivor details how her immunotherapy changed her cancer journey for the better, and how ongoing trials of immunotherapy are looking to change the cancer landscape for the better.
On taking a mental health break from cancer in order to rekindle a sense of hope.
An Extraordinary Healer essay honoring TINA FLOCCO, APN-BC, AOCNP [REGIONAL CANCER CARE ASSOCIATES, EAST BRUNSWICK, NEW JERSEY]
There's a heartbreaking reality of making a profession out of cancer, but I chose it anyway.
Carole Brennan Miller, M.D., head of the Cancer Institute at Saint Agnes Hospital, explains what makes people with myeloproliferative neoplasms (MPNs) unique, and why she finds it interesting to work with them.
Rural patients tend to have diminished access to appropriate, routine cancer screening studies, leading to patients with cancer being diagnosed with more advanced stage disease.
Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.
Rebecca N. Claassen discusses the importance of educating nurses about myeloproliferative neoplasms (MPNs).
Jame Abraham, Director of Cleveland Clinic's Breast Medical Oncology Program, provides an overview of what you shouldn't be afraid to ask your doctor.
Exercise can help prevent excess fatigue for survivors of cancer and other issues are explored in this summer issue of CURE.
Melanoma rates are on the rise, and is the most common form of cancer for young adults aged 25 to 29 years old.
The massive search for new drug candidates, amid haystacks of possibilities.
I haven’t written about cancer for about three months. That’s a long time for me.
Liquid biopsies may reveal who needs treatment for recurrent breast cancer — and, just as important, who doesn’t.
In 2011, I was told that I had a 10 percent chance of living. Five years later, my doctor refers to me as the miracle child.
Fans for the Cure is serving as an Advocacy Partner for the Metastatic Prostate Cancer Project (MPCP) — a nationwide genomic research initiative designed for men with advanced or metastatic prostate cancer — and they are working to advance prostate cancer research.
Two hematologist/oncologists on the LLS leadership team, and experts in the field of blood cancer, answer questions and concerns about coronavirus (COVID-19).
It is crucial to know all the side effects of the medication and surgeries you receive before starting cancer treatment.
Thomas Butler, M.D., medical oncologist at the University of Southern Alabama, Mitchell Cancer Institute, discusses the importance of shared decision making in cancer care.
RESEARCHERS ARE RE-EVALUATING WHAT CAUSES LYMPHEDEMA AGGRAVATION.
Comments from you, our readers, from the 2019 Spring issue of CURE®.
I have been in and out of chemotherapy and radiation for the past seven years, and my nurse Teri has always been by my side, making things a little less scary and a whole lot easier.
The legendary broadcast journalist Katie Couric sat down with CURE® to talk about founding the Jay Monahan Center for Gastrointestinal Health in honor of her late husband.